Does Rallies show Form 4 insider transactions for ECOR?

Yes. Rallies tracks ECOR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ECOR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ECOR. It does not provide personalized investment advice.

ECOR (electroCore, Inc. Common Stock) Stock Analysis - Insider Trades

electroCore, Inc. Common Stock (ECOR) is a publicly traded Healthcare sector company. As of May 21, 2026, ECOR trades at $6.13 with a market cap of $48.61M and a P/E ratio of -3.44. ECOR moved +2.29% today. Year to date, ECOR is +29.60%; over the trailing twelve months it is +15.44%. Its 52-week range spans $4.16 to $19.49. Analyst consensus is strong buy with an average price target of $16.62. Rallies surfaces ECOR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ECOR stock inside the company?

Recent ECOR insider activity includes Goldberger Daniel S sold 16.07K, Lev Joshua S. sold 2.50K, Goldberger Daniel S bought 1.00K, Lev Joshua S. sold 2.17K, and Errico Thomas J. bought 15.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ECOR Key Metrics

Key financial metrics for ECOR
Metric	Value
Price	$6.13
Market Cap	$48.61M
P/E Ratio	-3.44
EPS	$-1.77
Dividend Yield	0.00%
52-Week High	$19.49
52-Week Low	$4.16
Volume	0
Avg Volume	0
Revenue (TTM)	$34.90M
Net Income	$-15.38M
Gross Margin	87.25%

Recent ECOR Insider Trades

Goldberger Daniel S sold 16.07K (~$96.75K) on Apr 10, 2026.
Lev Joshua S. sold 2.50K (~$12.63K) on Dec 4, 2025.
Goldberger Daniel S bought 1.00K (~$4.84K) on Dec 2, 2025.
Lev Joshua S. sold 2.17K (~$13.39K) on Nov 12, 2025.
Errico Thomas J. bought 15.00K (~$67.05K) on Aug 11, 2025.

Latest ECOR News

Quell Plus Physical Therapy Reduces Fibromyalgia Pain by 1.2 Points in 384-Patient Trial — May 13, 2026
electroCore Posts 43% Revenue Growth to $9.6M, Adjusted EBITDA Loss Narrows 24% — May 6, 2026
electroCore Sets May 6 Q1 Webinar; Ecora Royalties Q1 Contribution Up 105% — Apr 29, 2026
electroCore Secures Two U.S. Patents, Extends IP Protection to 2039 — Mar 30, 2026
Ecora Royalties’ Base Metals Contribution Hits $28.5M, Profit Swings to $22.2M — Mar 26, 2026

ECOR Analyst Consensus

3 analysts cover ECOR: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.62.

Common questions about ECOR

Who is trading ECOR stock inside the company?: Recent ECOR insider activity includes Goldberger Daniel S sold 16.07K, Lev Joshua S. sold 2.50K, Goldberger Daniel S bought 1.00K, Lev Joshua S. sold 2.17K, and Errico Thomas J. bought 15.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ECOR?: Yes. Rallies tracks ECOR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ECOR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ECOR. It does not provide personalized investment advice.